CSIMarket
 
Infusystem Holdings Inc  (NYSEAMER: INFU)
 

Infusystem Holdings Inc's Suppliers Performance

INFU's Supply Chain




 
INFU Costs vs Sales of Suppliers Growth Infusystem Holdings Inc's cost of sales deteriorated by -3.77 % year on year, sequentially cost of sales grew by 10.84 % in Q2.

• More on INFU Suppliers



Infusystem Holdings Inc's cost of sales deteriorated by -3.77 % year on year, sequentially cost of sales grew by 10.84 % in Q2.

• More on INFU Suppliers




Infusystem Holdings Inc's Comment on Supply Chain


The company has established partnerships and distribution agreements with several durable medical equipment (DME) manufacturers and healthcare providers to support its healthcare supply chain services. In November 2022, it formed SI Healthcare Technologies, LLC in partnership with Sanara MedTech Inc. to deliver DME products aimed at improving patient outcomes and reducing care costs. In 2024, SI Healthcare Technologies entered into an exclusive distribution agreement with ChemoMouthpiece, LLC to market a product designed to reduce Oral Mucositis in cancer patients. In May 2025, the company acquired the assets of Apollo Medical Supply, a Florida-based wound care service provider, to enhance its wound care business and integrate advanced patient service fulfillment technology. The Device Solutions segment focuses on selling or renting infusion pumps and other DME, supplying treatment-related consumables, and providing biomedical recertification, maintenance, and repair services across various healthcare settings.

Infusystem Holdings Inc's Comment on Supply Chain


The company has established partnerships and distribution agreements with several durable medical equipment (DME) manufacturers and healthcare providers to support its healthcare supply chain services. In November 2022, it formed SI Healthcare Technologies, LLC in partnership with Sanara MedTech Inc. to deliver DME products aimed at improving patient outcomes and reducing care costs. In 2024, SI Healthcare Technologies entered into an exclusive distribution agreement with ChemoMouthpiece, LLC to market a product designed to reduce Oral Mucositis in cancer patients. In May 2025, the company acquired the assets of Apollo Medical Supply, a Florida-based wound care service provider, to enhance its wound care business and integrate advanced patient service fulfillment technology. The Device Solutions segment focuses on selling or renting infusion pumps and other DME, supplying treatment-related consumables, and providing biomedical recertification, maintenance, and repair services across various healthcare settings.







INFU's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Infusystem Holdings Inc 265.47 143.33 8.54 473
SUBTOTAL 0.00 0.00 0.00 -


Sources: Infusystem Holdings Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Infusystem Holdings Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.